BSE filing, NSE: CESC. Summary written from the filing by ALFA Finder's alert engine.
CESC Ltd: key numbers
- Share price
- ₹126.88
- Market cap
- ₹16,819 Cr
- Revenue (annual)
- ₹18,570 Cr
- Net profit (annual)
- ₹1,542 Cr
- P/E (TTM)
- 10.8×Sector 21.0×
- Promoter holding
- 52.11%+0.00% QoQ
- FII holding
- 11.49%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from CESC Ltd
All →CESC Other Announcement
CESC Ltd has submitted its shareholding pattern for the quarter ended September 30, 2026, in compliance with SEBI regulatory requirements.
CESC Other Announcement
This is a routine compliance filing submitting the quarterly certificate under Regulation 74(5) regarding dematerialization activity for the period ended September 30, 2026.
CESC Bags ₹40 Cr Order from Prism Johnson Limited
CESC's subsidiary Purvah Green Power signed a 25-year PPA with Prism Johnson for a 49.5 MW wind project. Prism Johnson will invest Rs. 40 Crore for a 26.5% stake.
- Value
- ₹40.00 Cr
- From
- Prism Johnson Limited (PJL)
- Execution
- 25 years
- wind power project
- 49.5 MW
CESC Debt & Borrowing: ₹150 Cr
CESC Limited fully redeemed Commercial Paper worth ₹150 Crore on September 23, 2026. This disclosure confirms the company's repayment of its debt obligations.
- Value
- ₹150.0 Cr
CESC Debt & Borrowing: ₹190 Cr
CESC approved issuance of 19,000 secured NCDs worth ₹190 crore via private placement. The 5-year rated debentures carry 1M MIBOR OIS + 2.20% p.a. coupon.
- Value
- ₹190.0 Cr
- Execution
- 5 years (24 Sep 2026 to 24 Sep 2031)
CESC Investor Presentation: Key Takeaways
CESC reports solid FY26 performance with Revenue at ₹18,927 Cr (+9% YoY) and PAT at ₹1,618 Cr (+13% YoY). The strategy pivots towards 10 GW renewables by 2030 and backward integration into solar manufacturing.
- Call
- Guides 100% growth
Other board meeting date announcements
All →Jenburkt Pharmaceuticals Board Meeting Date
Jenburkt Pharmaceuticals has intimated that its Board will meet on 3 Nov 2026 to consider Q2/H1-26 financial results. No decision has been taken yet.
Kingfa Science & Technology (India) Board Meeting Date
Kingfa informed exchanges its Board meeting is scheduled for November 5, 2026, to consider Q1/H1 FY27 unaudited results. Trading window stays closed until 48 hours post-announcement.
Orient Press Board Meeting Date
Orient Press Ltd intimated its Board meeting is scheduled for 05/11/2026, inter alia to approve unaudited Q3 FY27 results. The trading window stays closed till 48 hours after the intimation on 07/11/2026.
Surya Roshni Board Meeting Date
Surya Roshni's board will meet on November 7, 2026, to approve Q2 FY27 unaudited results. Trading window stays closed until November 9.
Prerna Infrabuild Board Meeting Date
Prerna Infrabuild will convene its board on 04/11/2026 to consider quarter results. The meeting is proposed under Regulation 33 of the LODR.
JSL Industries Board Meeting Date
JSL Industries intimates that its Board will meet on 5 Nov 2026 to consider unaudited Q1/H1 results. The trading window closes from 1 Oct 2026 until results are public.